FDA will reconsider decision barring copycat versions of Lilly weight loss drug

  • Posted on October 14, 2024
  • By The Hill
  • 2 Views
FDA will reconsider decision barring copycat versions of Lilly weight loss drug

The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and diabetes drug from its official shortage list and allow compounding pha…
continue reading...

Author
The Hill

You May Also Like